{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:20:23Z","timestamp":1793488823142,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00432-022-04086-y","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T11:06:13Z","timestamp":1654859173000},"page":"3227-3241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma"],"prefix":"10.1007","volume":"148","author":[{"given":"An-an","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4202-6626","authenticated-orcid":false,"given":"Mei-ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"4086_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101753","volume":"37","author":"LR Arslanbaeva","year":"2020","unstructured":"Arslanbaeva LR, Santoro MM (2020) Adaptive redox homeostasis in cutaneous melanoma. Redox Biol 37:101753. https:\/\/doi.org\/10.1016\/j.redox.2020.101753","journal-title":"Redox Biol"},{"issue":"10","key":"4086_CR2","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1158\/1078-0432.CCR-20-4092","volume":"27","author":"MB Atkins","year":"2021","unstructured":"Atkins MB, Curiel-Lewandrowski C, Fisher DE et al (2021) The state of melanoma: emergent challenges and opportunities. Clin Cancer Res 27(10):2678\u20132697. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4092","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4086_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.det.2019.05.001","volume":"37","author":"L Bomar","year":"2019","unstructured":"Bomar L, Senithilnathan A, Ahn C (2019) Systemic therapies for advanced melanoma. Dermatol Clin 37(4):409\u2013423. https:\/\/doi.org\/10.1016\/j.det.2019.05.001","journal-title":"Dermatol Clin"},{"issue":"6","key":"4086_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA"},{"issue":"6","key":"4086_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","volume":"11","author":"RM Bremnes","year":"2016","unstructured":"Bremnes RM, Busund LT, Kilv\u00e6r TL et al (2016) The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. J Thorac Oncol 11(6):789\u2013800. https:\/\/doi.org\/10.1016\/j.jtho.2016.01.015","journal-title":"J Thorac Oncol"},{"key":"4086_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2401617","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen L, Wang J, Tan J, Wang S (2021) Identification of six autophagy-related-lncRNA prognostic biomarkers in uveal melanoma. Dis Mark 2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/2401617","journal-title":"Dis Mark"},{"key":"4086_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2033560","author":"LD Dillon","year":"2022","unstructured":"Dillon LD, McPhee M, Davidson RS et al (2022) Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study. Curr Med Res Opin. https:\/\/doi.org\/10.1080\/03007995.2022.2033560","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"4086_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.det.2019.06.001","volume":"37","author":"J Dowling","year":"2019","unstructured":"Dowling J, McGregor SP, Williford P (2019) Update on current treatment recommendations for primary cutaneous melanoma. Dermatol Clin 37(4):397\u2013407. https:\/\/doi.org\/10.1016\/j.det.2019.06.001","journal-title":"Dermatol Clin"},{"issue":"19","key":"4086_CR9","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","volume":"375","author":"AMM Eggermont","year":"2016","unstructured":"Eggermont AMM, Chiarion-Sileni V, Grob JJ et al (2016) Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med 375(19):1845\u20131855. https:\/\/doi.org\/10.1056\/NEJMoa1611299","journal-title":"N Engl J Med"},{"issue":"19","key":"4086_CR10","doi-asserted-by":"publisher","first-page":"23036","DOI":"10.18632\/aging.203594","volume":"13","author":"Y Fan","year":"2021","unstructured":"Fan Y, Liang X, Yu D (2021) Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Aging 13(19):23036\u201323071. https:\/\/doi.org\/10.18632\/aging.203594","journal-title":"Aging"},{"key":"4086_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2020.10.016","volume":"143","author":"T Gambichler","year":"2021","unstructured":"Gambichler T, Tsagoudis K, Kiecker F et al (2021) Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I\u2013III patients. Eur J Cancer 143:11\u201318. https:\/\/doi.org\/10.1016\/j.ejca.2020.10.016","journal-title":"Eur J Cancer"},{"key":"4086_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/417281","volume":"2015","author":"C Giampietri","year":"2015","unstructured":"Giampietri C, Petrungaro S, Conti S, Facchiano A, Filippini A, Ziparo E (2015) Cancer microenvironment and endoplasmic reticulum stress response. Mediators Inflamm 2015:1\u201311. https:\/\/doi.org\/10.1155\/2015\/417281","journal-title":"Mediators Inflamm"},{"issue":"10","key":"4086_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.21037\/atm-21-1794","volume":"9","author":"JH Guo","year":"2021","unstructured":"Guo JH, Yin SS, Liu H, Liu F, Gao FH (2021) Tumor microenvironment immune-related lncRNA signature for patients with melanoma. Ann Transl Med 9(10):857\u2013857. https:\/\/doi.org\/10.21037\/atm-21-1794","journal-title":"Ann Transl Med"},{"issue":"3","key":"4086_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1755-148X.2008.00467.x","volume":"21","author":"P Hersey","year":"2008","unstructured":"Hersey P, Zhang XD (2008) Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res 21(3):358\u2013367. https:\/\/doi.org\/10.1111\/j.1755-148X.2008.00467.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"4086_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/ijms21031106","volume":"21","author":"SV Hindupur","year":"2020","unstructured":"Hindupur SV, Schmid SC, Koch JA et al (2020) STAT3\/5 inhibitors suppress proliferation in bladder cancer and enhance oncolytic adenovirus therapy. IJMS 21(3):1106. https:\/\/doi.org\/10.3390\/ijms21031106","journal-title":"IJMS"},{"issue":"18","key":"4086_CR17","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557\u20134566. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962","journal-title":"Cancer Res"},{"issue":"12","key":"4086_CR18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ et al (2018) Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50(12):1705\u20131715. https:\/\/doi.org\/10.1038\/s41588-018-0252-3","journal-title":"Nat Genet"},{"issue":"3","key":"4086_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT (2018) Functional classification and experimental dissection of long noncoding RNAs. Cell 172(3):393\u2013407. https:\/\/doi.org\/10.1016\/j.cell.2018.01.011","journal-title":"Cell"},{"issue":"16","key":"4086_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R et al (2019) Five-Year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381(16):1535\u20131546. https:\/\/doi.org\/10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"},{"key":"4086_CR21","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4287","author":"G Leonardi","year":"2018","unstructured":"Leonardi G, Falzone L, Salemi R et al (2018) Cutaneous melanoma: from pathogenesis to therapy (review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4287","journal-title":"Int J Oncol"},{"key":"4086_CR22","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.2147\/IJGM.S340025","volume":"14","author":"FW Li","year":"2021","unstructured":"Li FW, Luo SK (2021) Identification and construction of a predictive immune-related lncRNA signature model for melanoma. IJGM 14:9227\u20139235. https:\/\/doi.org\/10.2147\/IJGM.S340025","journal-title":"IJGM"},{"issue":"4","key":"4086_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1134\/S0006297917040095","volume":"82","author":"Y Li","year":"2017","unstructured":"Li Y, Shan Z, Liu C et al (2017) MicroRNA-294 promotes cellular proliferation and motility through the PI3K\/AKT and JAK\/STAT pathways by upregulation of NRAS in bladder cancer. Biochemistry Moscow 82(4):474\u2013482. https:\/\/doi.org\/10.1134\/S0006297917040095","journal-title":"Biochemistry Moscow"},{"key":"4086_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/7488188","volume":"2021","author":"Z Li","year":"2021","unstructured":"Li Z, Li Y, Zhong W, Huang P (2021a) m6A-related lncRNA to develop prognostic signature and predict the immune landscape in bladder cancer. J Oncol 2021:1\u201316. https:\/\/doi.org\/10.1155\/2021\/7488188","journal-title":"J Oncol"},{"issue":"1","key":"4086_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jcmm.15980","volume":"25","author":"X Li","year":"2021","unstructured":"Li X, Jin F, Li Y (2021b) A novel autophagy-related lncRNA prognostic risk model for breast cancer. J Cell Mol Med 25(1):4\u201314. https:\/\/doi.org\/10.1111\/jcmm.15980","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4086_CR26","doi-asserted-by":"publisher","first-page":"e28553","DOI":"10.1097\/MD.0000000000028553","volume":"101","author":"Z Li","year":"2022","unstructured":"Li Z, Wei J, Zheng H et al (2022) The new horizon of biomarker in melanoma patients: a study based on autophagy-related long non-coding RNA. Medicine (Baltimore) 101(1):e28553. https:\/\/doi.org\/10.1097\/MD.0000000000028553","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"4086_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.18240\/ijo.2021.08.03","volume":"14","author":"CL Liao","year":"2021","unstructured":"Liao CL, Sun XY et al (2021) Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma. Int J Ophthalmol 14(8):1151\u20131159. https:\/\/doi.org\/10.18240\/ijo.2021.08.03","journal-title":"Int J Ophthalmol"},{"key":"4086_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3389\/fonc.2019.00935","volume":"9","author":"N Liu","year":"2019","unstructured":"Liu N, Liu Z, Liu X, Chen H (2019) Comprehensive analysis of a competing endogenous RNA network identifies seven-lncRNA signature as a prognostic biomarker for melanoma. Front Oncol 9:935. https:\/\/doi.org\/10.3389\/fonc.2019.00935","journal-title":"Front Oncol"},{"issue":"4","key":"4086_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/2159-8290.CD-19-0069","volume":"9","author":"DB Lombard","year":"2019","unstructured":"Lombard DB, Cierpicki T, Grembecka J (2019) Combined MAPK pathway and HDAC inhibition breaks melanoma. Cancer Discov 9(4):469\u2013471. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0069","journal-title":"Cancer Discov"},{"issue":"10","key":"4086_CR31","first-page":"6524","volume":"12","author":"YL Peng","year":"2020","unstructured":"Peng YL, Wu ZS, Lu HM et al (2020) Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer. Am J Transl Res 12(10):6524\u20136536","journal-title":"Am J Transl Res"},{"issue":"11","key":"4086_CR32","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"4086_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2020.108321","volume":"785","author":"RA Rather","year":"2020","unstructured":"Rather RA, Bhagat M, Singh SK (2020) Oncogenic BRAF, endoplasmic reticulum stress, and autophagy: crosstalk and therapeutic targets in cutaneous melanoma. Mutat Res\/Rev Mutat Res 785:108321. https:\/\/doi.org\/10.1016\/j.mrrev.2020.108321","journal-title":"Mutat Res\/Rev Mutat Res"},{"issue":"1","key":"4086_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/or.2018.6430","volume":"40","author":"O Ryabaya","year":"2018","unstructured":"Ryabaya O, Prokofieva A, Khochenkov D, Abramov I, Zasedatelev A, Stepanova E (2018) Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment. Oncol Rep 40(1):385\u2013394. https:\/\/doi.org\/10.3892\/or.2018.6430","journal-title":"Oncol Rep"},{"issue":"13","key":"4086_CR35","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz SU, Grote P, Herrmann BG (2016) Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci 73(13):2491\u20132509. https:\/\/doi.org\/10.1007\/s00018-016-2174-5","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"4086_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM (2019) The role of non-coding RNAs in oncology. Cell 179(5):1033\u20131055. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017","journal-title":"Cell"},{"issue":"5\u20136","key":"4086_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10585-018-9893-y","volume":"35","author":"N Turner","year":"2018","unstructured":"Turner N, Ware O, Bosenberg M (2018) Genetics of metastasis: melanoma and other cancers. Clin Exp Metastasis 35(5\u20136):379\u2013391. https:\/\/doi.org\/10.1007\/s10585-018-9893-y","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"4086_CR38","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1080\/21645515.2017.1312043","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Yang L, Wang D, Zhang Q, Zhang L (2017) Pro-tumor activities of macrophages in the progression of melanoma. Hum Vaccin Immunother 13(7):1556\u20131562. https:\/\/doi.org\/10.1080\/21645515.2017.1312043","journal-title":"Hum Vaccin Immunother"},{"issue":"19","key":"4086_CR39","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M et al (2017) Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 377(19):1824\u20131835. https:\/\/doi.org\/10.1056\/NEJMoa1709030","journal-title":"N Engl J Med"},{"issue":"14","key":"4086_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R et al (2017) Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 377(14):1345\u20131356. https:\/\/doi.org\/10.1056\/NEJMoa1709684","journal-title":"N Engl J Med"},{"issue":"6","key":"4086_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7150\/ijms.42151","volume":"17","author":"Z Wu","year":"2020","unstructured":"Wu Z, Zhu K, Liu Q et al (2020) Profiles of immune infiltration in bladder cancer and its clinical significance: an integrative genomic analysis. Int J Med Sci 17(6):762\u2013772. https:\/\/doi.org\/10.7150\/ijms.42151","journal-title":"Int J Med Sci"},{"issue":"3","key":"4086_CR42","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/iid3.468","volume":"9","author":"B Xiao","year":"2021","unstructured":"Xiao B, Liu L, Li A et al (2021) Identification and validation of immune-related lncRNA prognostic signatures for melanoma. Immun Inflamm Dis 9(3):1044\u20131054. https:\/\/doi.org\/10.1002\/iid3.468","journal-title":"Immun Inflamm Dis"},{"key":"4086_CR43","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.2147\/IJGM.S335266","volume":"14","author":"L Xue","year":"2021","unstructured":"Xue L, Wu P, Zhao X et al (2021) Using immune-related lncRNA signature for prognosis and response to immunotherapy in cutaneous melanoma. IJGM 14:6463\u20136475. https:\/\/doi.org\/10.2147\/IJGM.S335266","journal-title":"IJGM"},{"issue":"21","key":"4086_CR44","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.3390\/ijms222112025","volume":"22","author":"M Yavartanoo","year":"2021","unstructured":"Yavartanoo M, Yi GS (2021) Development and validation of tumor immunogenicity based gene signature for skin cancer risk stratification. IJMS 22(21):12025. https:\/\/doi.org\/10.3390\/ijms222112025","journal-title":"IJMS"},{"issue":"1","key":"4086_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13059-018-1523-0","volume":"19","author":"E Zhang","year":"2018","unstructured":"Zhang E, He X, Zhang C et al (2018) A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol 19(1):154. https:\/\/doi.org\/10.1186\/s13059-018-1523-0","journal-title":"Genome Biol"},{"key":"4086_CR30","doi-asserted-by":"publisher","unstructured":"(2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(13):1270\u20131271. https:\/\/doi.org\/10.1056\/NEJMc1509660","DOI":"10.1056\/NEJMc1509660"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04086-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T07:07:09Z","timestamp":1666336029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4086"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04086-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Nanchang University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Our manuscript does not contains any individual data in any form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}